Physician profile
Nirav Patel
NPI 1598050486
$6,084.93
in general payments reported to CMS, 2019-2025
19 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $167 · 2022: $129 · 2023: $173 · 2024: $5,487 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Travel and Lodging: $1,155 · Food and Beverage: $635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Travel and Lodging | $1,154.67 |
| Food and Beverage | $634.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,171.66 | 2024 | |
| Wright Medical Technology, INC. | $154.41 | 2019 | |
| Pfizer INC. | $118.66 | 2023-2024 | |
| Fujifilm Healthcare Americas Corporation | $95.24 | 2024 | Fujifilm |
| Insmed, INC. | $92.07 | 2022-2023 | Arikayce |
| Exact Sciences Corporation | $72.35 | 2023 | Cologuard Collection Kit |
| Dendreon Pharmaceuticals LLC | $56.58 | 2025 | Provenge |
| Boston Scientific Corporation | $51.78 | 2024 | Spaceoar Vue System - 10ml |
| Actelion Pharmaceuticals US, INC. | $45.63 | 2024-2025 | Uptravi, Opsumit, Opsynvi |
| Shionogi INC | $41.77 | 2023 | Fetroja |
| Inogen, INC. | $32.53 | 2022 | |
| Vapotherm INC | $26.79 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.48 | 2024 | |
| Electromed, INC. | $20.92 | 2022 | |
| Lilly USA, LLC | $20.53 | 2025 | Zepbound |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $18.09 | 2025 | Venclose Maven Catheter |
| Progenics Pharmaceuticals, INC. | $16.75 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $14.22 | 2025 | Tezspire |
| Allergan, INC. | $12.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirav Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.